Tejara Capital’s Insmed INSM Stock Holding History

Tejara Capital’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-34,529	Closed	-$589K	–	87
2023 Q1	$589K	Hold	34,529	–	–	0.3%	58
2022 Q4	$690K	Buy	+34,529	New	+$667K	0.4%	54

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tejara Capital's INSM Position: Q2 2023 in Review

Tejara Capital sold out of Insmed (INSM) in Q2 2023, closing a stake of 34,529 shares — an estimated $589K sold.

Tejara Capital first reported a position in INSM in Q4 2022 and held it in 2 quarters. The position peaked at $690K in Q4 2022. 223 funds tracked by Wall St. Rank hold INSM as of Q2 2023.

Tejara Capital reported no remaining Insmed position as of Q2 2023 after selling out during the quarter.
Tejara Capital sold 34,529 Insmed shares in Q2 2023, an estimated $589K.
Tejara Capital first reported a position in Insmed in Q4 2022 and held it in 2 quarters.
Tejara Capital's Insmed position peaked at $690K in Q4 2022.
223 funds tracked by Wall St. Rank held Insmed as of Q2 2023.

Based on Tejara Capital's 13F filing for Q2 2023, filed 11 Aug 2023.